Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$31.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 10 | OCUL | Ocular Therapeutix, INC | AGRANT | 14,000 | — | — | +28.0% | Open the original filing on SEC.gov |
| May 18 | HROW | Harrow, INC. | PBUY | 1,000 | $31.07 | $31.1K | — | Open the original filing on SEC.gov |
| Apr 20 | IRD | Opus Genetics, Inc. | AGRANT | 24,367 | — | — | +23.6% | Open the original filing on SEC.gov |
| Jan 1 | IRD | Opus Genetics, Inc. | AGRANT | 23,643 | — | — | +29.7% | Open the original filing on SEC.gov |
| Jun 20, 2025 | HROW | Harrow, INC. | AGRANT◆ | 7,339 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | OCUL | Ocular Therapeutix, INC | AGRANT◆ | 44,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | OCUL | Ocular Therapeutix, INC | AGRANT | 14,000 | — | — | +38.9% | Open the original filing on SEC.gov |
| Apr 30, 2025 | IRD | Opus Genetics, Inc. | AGRANT◆ | 79,592 | — | — | — | Open the original filing on SEC.gov |
| Apr 30, 2025 | IRD | Opus Genetics, Inc. | AGRANT | 79,504 | — | — | — | Open the original filing on SEC.gov |